Inventor · disambiguated record
Fred Gluck
Also filed as: GLUCK FRED
5 granted patents·3 pending applications·272 citations·filing 2012–2023
87Inventor score
Top patents by PatentIndex Score
8 records- 0198US10875913B2Methods of treatment using activatable anti-EGFR antibodiesCYTOMX THERAPEUTICS INC·Filed 2018·Granted Dec 29, 2020·21 cites·40 claims
- 0298US10118961B2Modified antibody containing the cleavable peptide with the amino acid sequence TGRGPSWVCYTOMX THERAPEUTICS INC·Filed 2016·Granted Nov 6, 2018·34 cites·13 claims
- 0398US10059762B2Anti-EGFR activatable antibodiesCYTOMX THERAPEUTICS INC·Filed 2016·Granted Aug 28, 2018·42 cites·41 claims
- 0498US8513390B2Modified antibody compositions, methods of making and using thereofSTAGLIANO NANCY E·Filed 2012·Granted Aug 20, 2013·111 cites·137 claims
- 0596US9453078B2Modified antibody compositions, methods of making and using thereofCYTOMX THERAPETUICS INC·Filed 2013·Granted Sep 27, 2016·64 cites·28 claims
- 0690US2024228603A1Modified antibody compositions, methods of making and using thereofCYTOMX THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 0776US2021284721A1Modified antibody compositions, methods of making and using thereofCYTOMX THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 0862US2013309230A1Modified Antibody Compositions, Methods of Making and Using ThereofCYTOMX THERAPETUICS INC·Filed 2013·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Fred Gluck files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →